Evelo Biosciences, Inc.
EVLODelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001694665
Evelo Biosciences, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Nov 8, 2023; 29 institutions reported holding it in 13F filings for Q3 2023, worth $52.0M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Evelo Biosciences, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 25 | 29 | +4 |
| Shares | 3.60M | 13.3M | +9.65M (+267.9%) |
| Value | $11.3M | $52.0M | +$40.7M (+359.7%) |
New holders (6)
Institutions that held Evelo Biosciences, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 265,103 | $1.04M | 0.01% |
| Millennium Management LLC | 38,093 | $149.3K | 0.00% |
| Susquehanna International Group, LLP | 26,679 | $104.6K | 0.00% |
| Northern Trust Corp | 18,200 | $71.3K | 0.00% |
| The PNC Financial Services Group, Inc. | 180 | $706 | 0.00% |
| National Bank of Canada | 5 | $19 | 0.00% |
Sold out (2)
Institutions that held Evelo Biosciences, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Advisor Group Holdings, Inc. | 75 | $242 |
| Simplex Trading, LLC | 8 | $0 |